Your cart is currently empty!.
You may check out all the available products and buy some in the shop.
Continue Shopping● EQUITY REPORT
Abbott Laboratories (ABT) (Q3FY25) – From C-19 normalization to cancer screening leadership
Highlights of the report
Abbott’s product innovation trajectory demonstrates balanced pipeline construction with combination of iterative and transformative innovation, generating approximately $500 million in sales from recently launched products in Q3FY25 alone, contributing 100+bps to organic sales growth
CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.
CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).
Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Cologuard’s market-leading 95% colorectal cancer detection sensitivity and 20 million cumulative screening volumes since 2014 launch.
Abbott Laboratories last 3 months, the stock has given a return of (4.88%), with the stock price decreasing to $126.15 as of Nov 19, 2025, from $132.66 as of Aug 19, 2025.
Executive Summary
• CrispIdea Forecast
– Income Statement
– Balance Sheet
– Cash Flow
– Common Size Ratio Analysis
– CrispIdea Segment Forecast
• Valuation & Historical Performance
– P/E Analysis
– CrispIdea Valuation
– Peer Comparison
– Ratio Analysis
– Economic Value-Added Analysis
– Du Pont Analysis
– CrispIdea Forecast Relative to Consensus
– Consensus Momentum
– Segment Performance
– Key Developments
– M&A Deals
• Ownership
• Stock Price Performance
• Crispidea Coverage
https://www.crispidea.com/report/abbott-laboratories-abt-q2fy25/
Add Your Heading Text Here
Report details
Abbott Laboratories (ABT) (Q3FY25) – From C-19 normalization to cancer screening leadership
- Pages
- 29
- Format
- Language
- english
- Released
- November 24, 2025
- Last Updated
Price
$232.00
Company Reports
● EQUITY REPORT
Micron Technology, Inc. (Q3FY26) (MU) - The $100 billion backlog protecting your investment
● EQUITY REPORT
UiPath Inc. (PATH) (Q1FY27) - Agentic AI challenges traditional RPA
● EQUITY REPORT
Okta Inc Q1FY27 (OKTA) - AI potential still needs validation
● EQUITY REPORT
Hewlett Packard Enterprise (HPE) (Q2FY26) - Juniper strengthens networking business
● EQUITY REPORT
Conagra Brands Inc Q4FY26 (CAG) Persistent inflation limits margin recovery
● EQUITY REPORT
Autodesk Inc Q1FY27 (ADSK) - MaintainX expansion with margin risks
● APPAREL & FOOTWEAR
Nike Inc Q4FY26 (NKE) - Recovery slowed by macro uncertainty
● EQUITY REPORT
Broadcom Inc. Q2FY26 (AVGO) - The $30 billion AI backlog story
● EQUITY REPORT
MongoDB Inc Q1FY27 (MDB) - Enterprise AI becomes growth driver
● AUTOMOTIVE
Toyota Motor Corporation Q4FY26 (7203.T) Navigating external shocks via value chain growth
● APPAREL & FOOTWEAR
H & M Hennes & Mauritz AB Q2FY26 (HMb.ST) - Growth limited by supply constraints
● CP&E
HP Inc Q2FY26(HPQ) - Massive cash flows meet heavy share buybacks
● DIVERSIFIED INDUSTRIAL
ABB Ltd. (ABB) (Q2FY26) - Navigating segment divergence via disciplined capital allocation
● EQUITY REPORT
PepsiCo Inc. (PEP) (Q2FY26) - International strength faces cost pressures
● EQUITY REPORT
Marvell Technology Inc. (MRVL) (Q1FY27) - Marvell’s multi-year AI surge
● AEROSPACE & DEFENSE
AeroVironment Inc (AVAV) (Q4FY26) - Scaling manufacturing moat suppresses near-term EPS
● EQUITY REPORT
EnerSys (ENS) (Q4FY26) - Mitigating material handling cyclicality via technical mix shifts
● EQUITY REPORT
McCormick & Company Inc Q2FY26 (MKC) - Integration despite challenges
● EQUITY REPORT
Synopsys, Inc. (SNPS) (Q2FY26) - Fusion momentum balances IP weakness
- August 7, 2026
Mondelez International (Q2FY26)- Emerging Markets remained the company's strongest growth engine in Q2FY26, with organic revenue increasing 4.4%, supported by strong volume and mix performance across most snacking categories.
$240.00
- August 7, 2026
Hewlett Packard Enterprise delivered one of its strongest quarters as enterprise demand accelerated across networking, Cloud & AI, storage, and hybrid cloud.
$224.00
- August 7, 2026
Okta Inc Q1FY27 - Okta continues to strengthen its position within large enterprise customers, which remains the primary driver of recurring revenue growth.
$240.00
- August 7, 2026
UiPath is successfully evolving from a traditional RPA provider into an enterprise AI and process orchestration platform.
$240.00
Sector Reports
AUG 17, 2026
● SECTOR REPORTS
The Quantum Security-Resilience Beyond Q-Day
AUG 7, 2026
● SECTOR REPORTS
The "Hardware & Software" Metaphor
AUG 7, 2026
● SECTOR REPORTS
"ANTIQ" 1H26: THE COLLECTIVE SEMICONDUCTOR STOCK PERFORMANCE
AUG 7, 2026
● SECTOR REPORTS
Tokenization: Turning Real-World Value into Digital Opportunity
AUG 7, 2026
● SECTOR REPORTS
Humanoid Vol.1: The Dawn of the Embodied AI Revolution
AUG 7, 2026
● SECTOR REPORTS
Green Fintech 2026 Unlocking Value Across the Green Fintech Revolution
AUG 7, 2026
● SECTOR REPORTS
The Magnificent 7: Q1 2026 Performance
AUG 7, 2026
● SECTOR REPORTS
SpaceX IPO analysis: The rocket that reached everything
AUG 7, 2026
● SECTOR REPORTS
Data Center Industry Report 2026: The physical, and operational realities of data center infrastructure
AUG 7, 2026
● SECTOR REPORTS
The New Era of High Growth Tech: 50 Disruptors Harnessing AI for Global Scale
- August 17, 2026
This sector report provides a forward-looking assessment of the quantum cybersecurity landscape, analyzing how the rapid advancement of quantum computing is necessitating a fundamental shift toward quantum-resistant infrastructure.
$1,100.00
- August 7, 2026
As we approach 2026, the APAC region continues to stand out as a global growth engine. But for the institutional investor, the real “investment season” is happening right now.
$350.00
- August 7, 2026
Semiconductors remain vital to modern electronics, powering devices like smartphones, tablets, and PCs. While the industry has recovered from pandemic disruptions, it now faces geopolitical tensions, regulatory shifts, and supply chain diversification efforts.
$1,450.00
- August 7, 2026
Tokenization is reshaping how financial assets are issued, settled, and stored. The technology is proven, regulations are advancing, and major asset managers are already moving capital onto blockchain-based systems.
$230.00
